Skip to main content
SpringerLink
Log in

In vivo effects of apoE and clusterin on amyloid-β metabolism and neuropathology

  • Original Article
  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The ε4 allele of apolipoprotein E APOE is a risk factor for Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA), and the ε2 allele is associated with a decreased risk for AD. There is strong evidence to suggest that a major, if not the main, mechanism underlying the link between apoE and both AD and CAA is related to the ability of apoE to interact with the amyloid-β (Aβ) peptide and influence its clearance, aggregation, and conformation. In addition to a number of in vitro studies supporting this concept, in vivo studies with amyloid precursor protein (APP) transgenic mice indicate that apoE and a related molecule, clusterin (also called apolipoprotein J), have profound effects on the onset of Aβ deposition, as well as the local toxicity associated with Aβ deposits both in the brain parenchyma and in cerebral blood vessels. Taken together, these studies suggest that altering the expression of apoE and clusterin in the brain or the interactions between these molecules and Aβ would alter AD pathogenesis and provide new therapeutic avenues for prevention or treatment of CAA and AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bales K. R., Verina T., Cummins D. J., Du Y., Dodel J. C., Saura J., et al. (1999) Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 96, 15233–15238.

    Article  PubMed  CAS  Google Scholar 

  • Bales K. R., Verina T., Dodel R. C., Du Y., Altstiel L., Bender M., et al. (1997) Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat. Genet. 17, 263–264.

    Article  PubMed  CAS  Google Scholar 

  • Biere A. L., Ostaszewski B., Zhao H., Gillespie S., Younkin S. G., and Selkoe D. J. (1995) Co-expression of β-amyloid precursor protein (βAPP) and apolipoprotein E in cell culture: analysis of βAPP processing. Neurobiol. Dis. 2, 177–187.

    Article  PubMed  CAS  Google Scholar 

  • Brendza R. P., O’Brien C., Simmons K., McKeel D. W., Bales K. R., Paul S. M., et al. (2003) PDAPP;YFP double transgenic mice: a tool to study amyloid-β associated changes in axonal, dendritic, and synaptic structure. J. Comp. Neurol. 456, 375–383.

    Article  PubMed  CAS  Google Scholar 

  • Calero M., Rostagno A., Matsubara E., Zlokovic B., Frangione B., and Ghiso J. (2000) Apolipoprotein J (clusterin) and Alzheimer’s disease. Microsc. Res. Tech. 50, 305–315.

    Article  PubMed  CAS  Google Scholar 

  • Calhoun M. E., Burgermeister P., Phinney A. L., Stalder M., Tolnay M., Wiederhold K.- H., et al. (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. USA 96, 14088–14093.

    Article  PubMed  CAS  Google Scholar 

  • Castano E. M., Prelli F., Wisniewski T., Golabek A., Kumar R. A., Soto C., et al. (1995) Fibrillogenesis in Alzheimer’s disease of amyloid beta peptides and apolipoprotein E. Biochem. J. 306, 599–604.

    PubMed  CAS  Google Scholar 

  • Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923.

    Article  PubMed  CAS  Google Scholar 

  • Davis J. and Van Nostrand W. E. (1996) Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein. Proc. Natl. Acad. Sci. USA 93, 2996–3000.

    Article  PubMed  CAS  Google Scholar 

  • DeMattos R. B., Brendza R. P., Heuser J. E., Kierson M., Cirrito J. R., Fryer J. D., et al. (2001) Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochem. Int. 39, 415–425.

    Article  PubMed  CAS  Google Scholar 

  • DeMattos R. B., O’dell M. A., Parsadanian M., Taylor J. W., Harmony J. A. K., Bales K. R., et al. (2002a) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 99, 10843–10848.

    Article  PubMed  CAS  Google Scholar 

  • DeMattos R. B., Cirrito J. R., Parsadanian M., May P. C., O’Dell M. A., Taylor J. W., et al. (2004) ApoE and clusterin cooperatively suppress Aβ levels and deposition: Evidence that apoE regulates extracellular Aβ metabolism in vivo. Neuron 41, 193–202.

    Article  PubMed  CAS  Google Scholar 

  • DeMattos R. B., Parsadanian M., O’Dell M. A., Taylor J. W., Bales K. R., Paul S. M., et al. (2002b) Apolipoprotein E3 dose dependent modulation of Aβ deposition in a transgenic mouse model of Alzheimer’s disease. Soc. Neurosci. Abstr. 32, 723.

    Google Scholar 

  • Fagan A. M., Holtzman D. M., Munson G., Mathur T., Schneider D., Chang L. K., et al. (1999) Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-) and human apoE transgenic mice. J. Biol. Chem. 274, 30001–30007.

    Article  PubMed  CAS  Google Scholar 

  • Fagan A. M., Watson M., Parsadanian M., Bales K. R., Paul S. M., and Holtzman D. M. (2002) Human and murine apoE markedly influence Aβ metabolism both prior and subsequent to plaque formation in a mouse model of Alzheimer’s disease. Neurobiol. Dis. 9, 305–318.

    Article  PubMed  CAS  Google Scholar 

  • Fryer J. D., Taylor J. W., DeMattos R. B., Bales K. R., Paul S. M., Parsadanian M., and Holtzman D. M. (2003) Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in APP transgenic mice. J. Neurosci. 23, 7889–7896.

    PubMed  CAS  Google Scholar 

  • Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523–527.

    Article  PubMed  CAS  Google Scholar 

  • Ghiso J., Matsubara E., Koudinov A., Choi-Miura N. H., Tomita M., Wisniewski T., et al. (1993) The cerebrospinal-fluid form of Alzheimer’s amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293, 27–30.

    PubMed  CAS  Google Scholar 

  • Goate A., Chartier-Harlon M. C., Mullan M., Brown J., Crawford F., Fidani L., et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349, 704–706.

    Article  PubMed  CAS  Google Scholar 

  • Golde T. E., Eckman C. B., and Younkin S. G. (2000) Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s disease. Biochim. Biophys. Acta 1502, 172–187.

    PubMed  CAS  Google Scholar 

  • Gomez-Isla T., Price J. L., McKeel D. W., Morris J., C., Growdon J. H., and Hyman B. T. (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease. J. Neurosci. 16, 4491–4500.

    PubMed  CAS  Google Scholar 

  • Greenberg S. M., Rebeck G. W., Vonsattel J. P. G., Gomez-Isla T., and Hyman B. T. (1995) Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38, 254–259.

    Article  PubMed  CAS  Google Scholar 

  • Holtzman D. M. (2001) Role of apoE/Aβ interactions in the pathogenesis of Alzheimer’s disease and cerebral amyloid angiopathy. J. Mol. Neurosci. 17, 147–155.

    Article  PubMed  CAS  Google Scholar 

  • Holtzman D. M., Bales K. R., Tenkova T., Fagan A. M., Parsadanian M., Sartorius L. J., et al. (2000a) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 97, 2892–2897.

    Article  PubMed  CAS  Google Scholar 

  • Holtzman D. M., Bales K. R., Wu S., Bhat P., Parsadanian M., Fagan A. M., et al. (1999) In vivo expression of apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimers disease. J. Clin. Invest. 103, R15-R21.

    PubMed  CAS  Google Scholar 

  • Holtzman D. M., Fagan A. M., Mackey B., Tenkova T., Sartorius L., Paul S. M., et al. (2000b) ApoE facilitates neuritic and cerebrovascular plaque formation in the APPsw mouse model of Alzheimer’s disease. Ann. Neurol. 47, 739–747.

    Article  PubMed  CAS  Google Scholar 

  • Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Youkin S., et al. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99–102.

    Article  PubMed  CAS  Google Scholar 

  • Joachim C. L., Duffy L. K., Morris J. H., and Selkoe D. J. (1988) Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer’s disease and normal aging. Brain Res. 474, 100–111.

    Article  PubMed  CAS  Google Scholar 

  • Kindy M. S. and Rader D. J. (1998) Reduction in amyloid A formation in apolipoprotein-E-deficient mice. Am. J. Pathol. 152, 1387–1395.

    PubMed  CAS  Google Scholar 

  • LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S., and Frail D. E. (1994) Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269, 23404–23406.

    Google Scholar 

  • LaDu M. J., Gilligan S. M., Lukens S. R., Cabana V. G., Reardon C. A., Van Eldik L. J., et al. (1998) Nascent astrocyte particles differ from lipoproteins in CSF. J. Neurochem. 70, 2070–2081.

    Article  PubMed  CAS  Google Scholar 

  • Lai F. and Williams R. S. (1989) A prospective study of Alzheimer disease in Down syndrome. Arch. Neurol. 46, 849–853.

    PubMed  CAS  Google Scholar 

  • Lambert M. P., Barlow A. K., Chromy B. A., Edwards C., Freed R., Liosatsos M., et al. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448–6453.

    Article  PubMed  CAS  Google Scholar 

  • Levy E., Carman M. D., Fernandez-Madrid I., et al. (1990) Mutation of the Alzheimer’s beta-protein gene in amyloid of hereditary cerebral hemorrhage. Science 248, 1124–1126.

    Article  PubMed  CAS  Google Scholar 

  • Ma J., Yee A., Brewer H. B., Das S., and Potter H. (1994) Amyloid-associated proteins alpha-1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372, 92–94.

    Article  PubMed  CAS  Google Scholar 

  • Matsubara E., Frangione B., and Ghiso J. (1995) Characterization of apolipoprotein J-Alzheimer’s Aβ interaction. J. Biol. Chem. 270, 7563–7567.

    Article  PubMed  CAS  Google Scholar 

  • Matsubara E., Soto C., Governale S., Frangione B., and Ghiso J. (1996) Apolipoprotein J and Alzheimer’s amyloid beta solubility. Biochem. J. 316, 671–679.

    PubMed  CAS  Google Scholar 

  • May P. C. and Finch C. E. (1992) Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration. Trends Neurol. Sci. 15, 391–396.

    Article  CAS  Google Scholar 

  • May P. C., Lampert-Etchells M., Johnson S. A., Poirier J., Masters J. N., and Finch C. E. (1990) Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer’s disease and in response to experimental lesions in rat. Neuron 5, 831–839.

    Article  PubMed  CAS  Google Scholar 

  • Morris J. C. and Price J. L. (2001) Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer’s disease. J. Mol. Neurosci. 17, 101–118.

    Article  PubMed  CAS  Google Scholar 

  • Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., et al. (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of β-amyloid. Nat. Genet. 1, 345–347.

    Article  PubMed  CAS  Google Scholar 

  • Nilsberth C., Westlind-Danielsson A., Eckman C. B., Condron M. M., Axelman K., Forsell C., et al. (2001) The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Aβ protofibril formation. Nat. Neurosci. 4, 887–893.

    Article  PubMed  CAS  Google Scholar 

  • Oda T., Wals P., Osterburg H. H., Johnson S. A., Pasinetti G. M., Morgan T. M., et al. (1995) Clusterin (apoJ) alters the aggregation of amyloid β-peptide (Aβ1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp. Neurol. 136, 22–31.

    Article  PubMed  CAS  Google Scholar 

  • Price J. L. and Morris J. C. (1999) Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann. Neurol. 45, 358–368.

    Article  PubMed  CAS  Google Scholar 

  • Price J. L., Ko A. I., Wade M. J., Tsou S. K., McKeel D. W., and Morris J. C. (2001) Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer Disease. Arch. Neurol. 58, 1395–1402.

    Article  PubMed  CAS  Google Scholar 

  • Roheim P. S., Carey M., Forte T., and Vega G. L. (1979) Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. USA 76, 4646–4649.

    Article  PubMed  CAS  Google Scholar 

  • Rumble B., Retalack R., Hilbich C., Simms G., Multhaup G., Martins R., et al. (1989) Amyloid A4 protein and its precursors in Down’s syndrome and Alzheimer’s disease. N. Engl. J. Med. 320, 1446–1452.

    Article  PubMed  CAS  Google Scholar 

  • Sanan D. A., Weisgraber K. H., Russel S. J., Mahley R. W., Huang D., Saunders A., et al. (1994) Apolipoprotein E associates with β amyloid peptide of Alzheimer’s disease to form novel monofibrils. J. Clin. Invest. 94, 860–869.

    Article  PubMed  CAS  Google Scholar 

  • Strittmatter W. J. and Roses A. D. (1996) Apolipoprotein E and Alzheimer’s disease. Annu. Rev. Neurosci. 19, 53–77.

    Article  PubMed  CAS  Google Scholar 

  • Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., et al. (1993) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977–1981.

    Article  PubMed  CAS  Google Scholar 

  • Sullivan P. M., Mezdour H., Aratani Y., Knouff C., Najib J., Reddick R. L., et al. (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272, 17972–17980.

    Article  PubMed  CAS  Google Scholar 

  • Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L. J., Eckman C., et al. (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 1336–1340.

    Article  PubMed  CAS  Google Scholar 

  • Vinters H. V. (1987) Cerebral amyloid angiopathy: A critical review. Stroke 18, 311–324.

    PubMed  CAS  Google Scholar 

  • Wisniewski K. E., Wisniewski H. M., and Wen G. Y. (1985) Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann. Neurol. 17, 278–282.

    Article  PubMed  CAS  Google Scholar 

  • Yamaguchi H., Sugihara S., Ogawa A., Oshima N., and Ihara Y. (2001) Alzheimer beta amyloid deposition enhanced by ApoE epsilon 4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects. J. Neuropathol. Exp. Neurol. 60, 731–739.

    PubMed  CAS  Google Scholar 

  • Zlokovic B. V., Martel C. L., Mackic J. B., Matsubara E., Wisniewski T., McComb J. G., et al. (1994) Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer’s amyloid β. Biochem. Biophys. Res. Commun. 205, 1431–1437.

    Article  PubMed  CAS  Google Scholar 

  • Zlokovic B. V., Martel C. L., Matsubara E., McComb J. G., Zheng G., McCluskey R. T., et al. (1996) Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer’s disease amyloid β at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl. Acad. Sci. USA 93, 4229–4234.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for the Study of Nervous System Injury, Alzheimer’s Disease Research Center, Departments of Neurology, and Molecular Biology and Pharmacology, Washington University School of Medicine, 63110, St. Louis, MO

    David M. Holtzman

Authors
  1. David M. Holtzman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David M. Holtzman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holtzman, D.M. In vivo effects of apoE and clusterin on amyloid-β metabolism and neuropathology. J Mol Neurosci 23, 247–254 (2004). https://doi.org/10.1385/JMN:23:3:247

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/JMN:23:3:247

Index Entries

Search

Navigation